Lymphoma; Patient Education and Counseling; Colon Cancer; Lung Cancer; Today

A study led by researchers from Mayo Clinic Comprehensive Cancer Center has found that the addition of brentuximab vedotin to standard chemotherapy treatment improves overall survival in patients with Hodgkin Lymphoma, when compared to the…